News
News-Medical.Net on MSN37m
Innovative CAR-T cell therapy achieves remarkable results in patients with refractory CD30+ lymphomaResearchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep Carreras Leukaemia Research Institute, have developed an innovative CAR-T cell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback